Skip to main content
. 2017 Feb 3;12(2):e0158406. doi: 10.1371/journal.pone.0158406

Table 3. Overall survival for STS: multivariate analysis.

Factors HR 95% CI p-value
Interaction between Adherence to CPGs for surgery and setting (non-expert vs expert hospitals) 0.010

  • Adherence to CPGs for surgery in Non expert hospitals

  • Adherence to CPGs for surgery in expert hospitals

  • -

  • 0·34

  • -

  • 0·16–0·68

  • 0·99

  • 0·003
Age in years (≤ 60 vs. > 60) 0·4 0·26–0·62 <0·001
Sex (W vs. M) 0·56 0·38–0·83 0·004
Grade <0·0001

  • Intermediate vs. High

  • Low vs. High

  • 0·40

  • 0·12

  • 0·24–0·65

  • 0·07–0·22
Histology (Liposarcoma are the reference) 0·03

  • Angiosarcoma

 2·54 1·15–5·63

  • Dermatofibrosarcoma protuberans

 0·36 0·05–2·71

  • Leiomyosarcoma

 0·85 0·46–1·59

  • Malignant peripheral nerve sheath tumor

 0·67 0·20–2·29

  • Myxofibrosarcoma

 0·40 0·15–1·08

  • Soft tissue osteosarcoma

 1·57 0·56–4·38

  • Rhabdomyosarcoma

 1·46 0·48–4·45

  • Unclassified sarcoma

 0·68 0·39–1·22

  • Synovial sarcoma

 0·56 0·16–1·93

  • Solitary fibrous tumor + hemangioendothelioma

 0·85 0·29–2·51

  • Others

 1·3 0·52–3·28